Background: Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in
patients with advanced symptoms of heart failure. Purpose: To assess the benefits and …

Over the last 10 years, several large, well-designed clinical trials have firmly established the
role of cardiac resynchronization therapy (CRT) as a recommended treatment strategy for …

Background—Previous studies have reported conflicting findings regarding how the
incidence of heart failure (HF) after acute myocardial infarction (AMI) has changed over time …

Background—Heart failure (HF) and atrial fibrillation (AF) share common risk factors and
often coexist. The combination of HF and AF may carry a worse prognosis than either …

Aims The choice of resynchronization therapy between with (CRT-D) and without (CRT-P) a
defibrillator remains a contentious issue. Cause-of-death analysis among CRT-P, compared …

Background and Objectives Implantation of cardiac implantable electronic devices (CIED),
including permanent pacemakers (PM), implantable cardioverter-defibrillators (ICD), and …

Aims Guidelines have been published for improving management of chronic heart failure
(CHF). We examined the association between improved guideline adherence and risk for all …

Background Left bundle branch block (LBBB) morphology is associated with improved
outcome of cardiac resynchronisation therapy (CRT) and is an important criterion for patient …

Background There is evidence that implantable cardioverter‐defibrillator (ICD) for primary
prevention in people with an ischaemic cardiomyopathy improves survival rate. The …

Aims Cardiac resynchronization therapy (CRT) leads to reverse ventricular remodelling,
improved functional capacity, and better clinical outcome in patients with advanced chronic …